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Cell protrusions contribute to cell motility and migration by mediating the outward extension and initial adhesion of cell
edges. In many cells, these extensions are supported by actin bundles assembled by the actin cross-linking protein, fascin.
Multiple extracellular cues regulate fascin and here we focus on the mechanism by which the transmembrane proteo-
glycan, syndecan-1, specifically activates lamellipodial cell spreading and fascin-and-actin bundling when clustered either
by thrombospondin-1, laminin, or antibody to the syndecan-1 extracellular domain. There is almost no knowledge of the
signaling mechanisms of syndecan-1 cytoplasmic domain and we have tested the hypothesis that the unique V region of
syndecan-1 cytoplasmic domain has a crucial role in these processes. By four criteria—the activities of N-cadherin/V
region chimeras, syndecan-1 deletion mutants, or syndecan-1 point mutants, and specific inhibition by a membrane-
permeable TAT-V peptide—we demonstrate that the V region is necessary and sufficient for these cell behaviors and map
the molecular basis for its activity to multiple residues located across the V region. These activities correlate with a
V-region-dependent incorporation of cell-surface syndecan-1 into a detergent-insoluble form. We also demonstrate
functional roles of syndecan-1 V region in laminin-dependent C2C12 cell adhesion and three-dimensional cell migration.
These data identify for the first time specific cell behaviors that depend on signaling through the V region of syndecan-1.
INTRODUCTION
Cell adhesion and migration are important for cell and tissue
organization in metazoan organisms. Both processes depend
critically on the assembly of appropriate cell contact struc-
tures that mediate the interaction of cells with their environ-
ment. At molecular level, these structures are assembled
through the coordinated activation and spatial organization
of cell-surface adhesion receptors, intracellular signaling
cascades and cytoskeletal components (reviewed by Geiger
et al., 2001; Webb et al., 2003). Among the many forms of
cell-contacts, cell protrusions are of importance in cell mo-
tility and migration by mediating the outward extension of
the cell leading edge (reviewed by Adams, 2002; DeMali and
Burridge, 2003). This expansion of the plasma membrane is
supported by rigid yet elastically flexible actin meshworks
that contain parallel F-actin bundles (Svitkina et al., 2003). In
many cells, these bundles are cross-linked by the protein
fascin. Fascin is under complex regulation in cells, from
other actin-binding proteins and from extracellular cues pro-
vided by extracellular matrix and polypeptide factors (re-
viewed by Adams, 2004). The intracellular mechanisms that
relay these cues are not widely studied, yet are of general
interest for understanding the regulation and function of cell
protrusions. In this regard, this laboratory has established
that the extracellular glycoprotein, thrombospondin-1 (TSP-
1), has distinct activities in inducing cells to form fascin-
containing protrusions. This activity of TSP-1 is dependent
on the transmembrane proteoglycan, syndecan-1, and can be
mimicked by antibody ligation of the syndecan-1 extracel-
lular domain (Adams, 1995; Adams et al., 2001; reviewed by
Kureishy et al., 2002).
Syndecan-1 is a member of a gene family of proteoglycans
that function in the regulation of cell adhesion, migration,
and proliferation in many organisms. For example, overex-
pression of Ciona syndecan mRNA during embryogenesis of
Ciona savignyi results in delay and impairment of blastopore
closure, leading to morphological abnormalities in later em-
bryogenesis such as forking of the tail (Satou et al., 1999). In
Xenopus embryos, syndecan-2 mediates formation of the
left/right axis that is necessary for asymmetric placement of
the developing heart (Kramer and Yost, 2002). Gene knock-
out or overexpression of syndecan-1 result in reduced cell
migration during wound-healing and loss of susceptibility
to Wnt-mediated mammary tumorigenesis (Alexander et al.,
2000; Stepp et al., 2002; Elenius et al., 2004). These complex
and yet distinct functions relate to the common and unique
attributes of syndecan primary structure. Each family mem-
ber has a unique extracellular domain sequence, but all
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contain sites for addition of glycosaminoglycan (GAG)
chains proximal to the amino-terminus (reviewed by Ra-
praeger and Ott, 1998; Bernfield et al., 1999). Many functions
of syndecans result from their activities as coreceptors
through the binding of growth factors to the GAG chains
(for example, Kramer and Yost, 2002; Johnson et al., 2004;
Steigemann et al., 2004). The transmembrane domains are
highly conserved and the short cytoplasmic domains con-
tain two conserved regions, C1 and C2, that have the same
sequence in all syndecan family members. C1 and C2 are
separated by a variable (V) region that is unique to each
syndecan family member but also highly conserved between
species orthologues. The C2 region acts as a binding site for
PDZ domain-containing proteins and thus links all synde-
cans to a common set of binding proteins (reviewed by
Tkachenko et al., 2005). For syndecan-2 and -4, there is
increasing evidence for direct signaling roles of the cytoplas-
mic domains, that are specifically mediated by the V regions.
Serine-phosphorylation within the V region of syndecan-2 is
necessary for left/right axis formation in Xenopus embryos
(Kramer et al., 2002). Syndecan-4 regulates focal adhesion
assembly by V-region-dependent activation of protein ki-
nase C (PKC) and binding of -actinin (reviewed by Couch-
man, 2003).
In the case of syndecan-1, most attention has focused on
its activity as a coreceptor and almost nothing is known
about the functions or molecular mechanisms of the cy-
toplasmic domain apart from the C2 region (reviewed by
Rapraeger 2001; Tkachenko et al., 2005). The C1 region is
necessary for trafficking of syndecan-1 to the cell-surface
(Miettinen et al., 1994). Clustering of the complete trans-
membrane and cytoplasmic domains in Chinese hamster
ovary cells triggers incorporation into a detergent-insol-
uble membrane fraction and subsequent endocytosis, by
an unknown mechanism (Fuki et al., 2000). There are also
indications of regulation by tyrosine phosphorylation.
Constitutive endogenous tyrosine phosphorylation of
syndecan-1 has been reported in certain cells, although
the sites of phosphorylation and mechanism of regulation
are unknown (Ott and Rapraeger, 1998). Tyrosine 300 has
been implicated in the process by which syndecan-1 be-
comes colocalized with actin microfilaments in long-term
adherent cells, but again there is no information on the
mechanism (Carey et al., 1996). Thus, the mechanisms of
action of syndecan-1 cytoplasmic domain remain almost
completely unexplored.
Through our studies of fascin-containing cell protrusions,
we have identified dramatic effects of syndecan-1 ligation on
lamellipodial spreading and the formation of fascin and
actin bundles (Adams et al., 2001). These phenotypes depend
on syndecan-1 cytoplasmic domain and provide a robust
experimental system with which to examine the mechanism
by which the cytoplasmic domain transduces specific cy-
toskeletal organization. Here, we investigate the hypothesis
that the V region has a critical role in this process. We
establish that the transduction mechanism depends on the V
region independent of the C2 region and define critical
amino acids within the V region. We also demonstrate that
the V-region-mediated contribution of syndecan-1 to cell
protrusions is functionally relevant to ECM adhesion and
three-dimensional (3-D) cell migration and depends on its
incorporation into a detergent-insoluble fraction. Our find-
ings identify an important novel role of syndecan-1 V re-
gion.
MATERIALS AND METHODS
Cells and Other Materials
COS-7 green monkey kidney cells were cultured in DMEM containing 10%
fetal calf serum (FCS). C2C12 mouse skeletal myoblasts were grown in
DMEM containing 20% FCS. All cells were maintained at 37°C in a humidified
5% CO2 atmosphere. Mouse syndecan-1 cDNA and the TGM mutant in which
the S37, S45, and S47 sites for GAG addition are mutated to alanines were the
gifts of Ralph Sanderson (Langford et al., 1998). Chicken N-cadherin (NCAD)
cDNA (Hatta et al., 1988) in the pCR3 vector was a gift from Robert Kypta
(Imperial College, London). Rat monoclonal antibody (mAb) 281-2 to mouse
syndecan-1 core protein (Jalkanen et al., 1985) was obtained from BD Phar-
mingen (San Diego, CA) in native or biotin-conjugated forms. Antibody ID4
to human syndecan-1 (Bobardt et al., 2004) was from ImmunoKontact (Wies-
baden, Germany). Mouse mAb 55k2 to fascin-1 was obtained from Dako
(Glostrup, Denmark). Antibodies to chicken N-cadherin included the mouse
mAb FA-5 (Volk et al., 1990; Sigma-Aldrich, Poole, Dorset, United Kingdom),
and the rat mAb NCD-2 (Hatta and Takeichi, 1986; Zymed Laboratories,
Berlin, Germany). Mouse mAb against -tubulin, (TUB 2.1-FITC conjugate),
was obtained from Sigma-Aldrich. Fluorescein isothiocyanate (FITC)- and
tetramethyl rhodamine isothiocyanate- (TRITC) secondary antibodies against
mouse immunoglobulins were obtained from ICN Biomedicals (Irvine, CA).
Fluorescein-streptavidin was from Vector Laboratories (Burlingame, CA).
Phalloidin conjugated to TRITC and secondary antibodies to rat immuno-
globulins were obtained from Sigma-Aldrich. Membrane-permeable TAT
peptides were synthesized by Genemed Synthesis (South San Francisco, CA)
and included TAT only (YGRKKRRQRRR); TAT-V (YGRKKRRQR-
RRGQANGGAYQKPTKQE); a scrambled control, TAT-Vscr, (YGRKKRRQR-
RRGQQATGKENAKGYPQ); and a mutant peptide, TAT-VMUT5
(YGRKKRRQRRRGKAANVVAYAKPTGQ). The peptides were synthesized
with N-terminal acetylation and C-terminal amidation and were HPLC-pu-
rified to 90% purity.
Preparation of Syndecan-1 Mutant and Chimeric
Expression Constructs
A series of truncation mutations of mouse syndecan-1 (T1–T4), were prepared
by PCR-based mutagenesis of the wild-type cDNA by use of the oligonucle-
otide primers shown in Table 1 (all oligonucleotides synthesized by Sigma-
Genosys). The PCR products of appropriate sizes were cloned into
pcDNA3.1/V5-His TOPO mammalian expression vector by the TOPO clon-
ing method according to the manufacturer’s procedures (Invitrogen, Carls-
bad, CA). Each reverse primer included a stop codon so that the encoded
proteins would be expressed in untagged form. S1–T3 and S1–T4 cDNAs were
generated by use of S1–T2 as a template. Point mutations were generated in
the VC2 region of full-length mouse syndecan-1 in the pcDNA3.1 plasmid by
use of QuickChange I or QuickChange II Site-directed mutagenesis kits
(Stratagene, La Jolla, CA). The oligonucleotide primers used for each point
mutation are shown in Table 1. To create a chimera with N-cadherin (NCAD),
the portion of the chicken NCAD coding sequence corresponding to amino
acids (aa) 1–759 was amplified by PCR using primers 109F and 105R or 109F
and 106R (Table 1). 106R added a HpaI site 3 to the NCAD cDNA and 105R
encoded a stop codon for the negative-control construct, NCADt. The 2280-
base pair PCR product was subcloned into pcDNA3.1/V-5-His by TOPO
cloning. The chimeric NCADt/syn-1VC2 or NCADt/syn-1V constructs were
prepared by insertion of cDNAs encoding either the VC2 portion of mouse
syndecan-1 (aa 287–311) or the V region only (aa 287–307) prepared by PCR
with primers 107F and 109R, or 107F and 104R, respectively. These primer
pairs introduced a HpaI site at the 5-end and a XbaI site at the 3-end of the
cDNAs. After digestion of both VC2 or V and pcDNA3.1/NCADt with HpaI
and XbaI, VC2 or V cDNA was ligated in frame 3 to the NCADt cDNA. This
procedure inserted a valine (V) and an asparagine (N) residue between
NCADt and the syndecan-1 portion. In all cases, the 5 and 3 junctions of
each new construct and the sites of point mutation were confirmed either by
manual DNA sequencing using the dideoxy chain-termination method (Se-
quenase Version 2.0 DNA sequencing Kit, United States Biological, Swamp-
scott, MA) or by automated DNA sequencing by the CCF Molecular Biotech-
nology Core (Cleveland, OH) using either standard T7R1 forward and BGH
reverse vector primers or an internal primer, 5AGGAAGGAAGTGCTGG-
GAGGT. Complete verification that the cDNA sequences did not contain any
additional mutations was carried out by automated DNA sequencing, either
at MGW Biotech DNA sequencing services (Ebersberg, Germany), or at the
CCF Molecular Biotechnology Core, using a set of vector and internal primers
to sequence each DNA on both strands. The deletion constructs were first
tested for protein expression by in vitro translation, using 1 g of each DNA
template in the Promega TNT T7 Quick coupled Transcription/Translation
System (Madison, WI). Translation products were resolved on 12% polyacryl-
amide gels and syndecan-1 detected by Western blotting with 281-2 mAb,
alkaline phosphatase-conjugated anti-rat IgG and enhanced chemilumines-
cent (ECL) detection as described previously (Adams et al., 2001). In live cells,
expression levels of mutant syndecans were compared with the wild-type
protein by immunostaining with 281-2 antibody, which is specific to mouse
syndecan-1 (Jalkanen et al., 1985), followed by fluorescence-activated cell
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sorting (FACS). SDS-PAGE and immunoblotting were carried out as de-
scribed (Anilkumar et al., 2003).
Transient expression and Syndecan-1 Cytoskeletal
Organization Assay
COS-7 or C2C12 cells for transient expression experiments were plated at
25–50% confluency and cotransfected with 3 g of syndecan-1 expression
plasmid DNA and 1 g of either enhanced green fluorescent protein expres-
sion plasmid (EGFPC1, Clontech Laboratories, Heidelberg, Germany) or
EGFP-fascin (Adams and Schwartz, 2000) per 60-mm dish by use of Polyfect
reagent (Qiagen, Crawley, West Sussex, United Kingdom) according to man-
ufacturer’s instructions. Cells were used for experiments 40–42 h after trans-
fection. For the cytoskeletal organization assays, glass coverslips were coated
at 4°C overnight with 50 g/ml 281-2 antibody to mouse syndecan-1, or
NCAD antibodies FA-5 or NCD-2, or 50 nM of baculovirus-expressed throm-
bospondin-1 (TSP-1; Adams et al., 1998), fibronectin (FN; Calbiochem, La Jolla,
CA) or EHS laminin (LN; Sigma, St. Louis, MO) and then rinsed in Tris-
buffered saline and blocked with 1 mg/ml heat-denatured bovine albumin
serum (bovine serum albumin [BSA]) for 1 h. Single-cell suspensions were
prepared by release in nonenzymatic cell dissociation medium (Cellgro,
Herndon, VA, or Sigma-Aldrich). Cell were washed three times in serum-free
DMEM, brought to 3  105 cells/ml, and plated on the coated surfaces for 1 h
at 37°C in serum-free DMEM. Nonattached cells were removed by rinsing in
phosphate-buffered saline (PBS) and the adherent cells were fixed for analysis
of cytoskeletal organization as described below. In some assays, cells were
pretreated with function-perturbing reagents. Membrane-permeable TAT
peptides were added at concentrations from 200 to 2000 nM to the culture
media for 1 h before harvesting cells. Pharmacological inhibitors, including
the microtubule-perturbing reagents paclitaxel or vinblastine sulfate (VBS;
each used at 10–20 M) or cytochalasin D (10–20 M) or Y27632 (10–20 nM)
were obtained from Calbiochem. These concentrations were established as
appropriate for maximal effects on cells and cytoskeleton without toxicity in
pilot experiments. Agents were added to the cells for 1 to 2 h before beginning
the experiments. All the agents were maintained throughout the experiments
at the same concentrations as used for pretreatment.
Immunofluorescence Staining and Morphometric Analysis
of Fascin-and-Actin Bundles
For indirect immunofluorescent staining for fascin, cells were fixed in abso-
lute methanol for 10 min. For staining for mouse syndecan-1, cells were fixed
in 3.7% formaldehyde. For examination of syndecan-1 extractability, cells
were subsequent permeabilized in PBS containing 0.5% Triton X-100. For
staining with phalloidin, or tubulin antibodies, cells were fixed in 3.7%
formaldehyde for 10 min and then permeabilized for 10 min in O’Neill buffer
(50 mM MES, pH 6.1, 5 mM MgCl2, 3 mM EGTA, 100 mM KCl, and 0.2%
Triton X-100; O’Neill et al., 1990). Primary antibodies were applied for 90 min,
and the cells washed three times in PBS and then stained with appropriate
fluorescence-conjugated secondary antibodies. For staining mouse synde-
can-1 in adherent cells, cells were incubated with biotinylated 281-2 antibody
to syndecan-1 for 90 min, and then with fluorescein-streptavidin for 40 min.
All samples were rinsed in PBS and distilled H2O and mounted on glass
microscope slides (BDH, Dagenham, Essex, United Kingdom) in Vectashield
mounting medium containing DAPI to visualize DNA and nuclei (Vector
Laboratories). Cells labeled with FITC or TRITC fluorochromes were exam-
ined by epifluorescence microscope using a Leica DMIRE2 inverted micro-
scope (Heidelberg, Germany) equipped with electronically controlled shut-
ters, filter wheel, and electronic focus. Images were captured under a 63
objective with 1.5 optical magnification with a Hamamatsu camera control-
ler C4742–95 (Bridgewater, NJ), run by Improvision Openlab software (ver-
sion 3.1.3; Lexington, MA). For quantification of cell area and the length and
number of fascin-actin bundles in each cell, digital PICT images were cali-
brated against a stage micrometer and analyzed morphometrically in Impro-
Table 1. Oligonucleotides used to prepare syndecan-1 cytoplasmic domain constructs and point mutants
Construct Primer no. Oligonucleotide sequence
S1 -T1 LMCB-74F 5-TCTGGGCAGCATGAGACG-3
LMCB-104R 5-CTACTCCTGCTTGGTGGGTTTCTG-3
S1-T2 LMCB-74F 5-TCTGGGCAGCATGAGACG-3
LMCB-153R 5-TTATTTCTGGTAGGCACCGCC-3
S1-T3 LMCB-74F 5-TCTGGGCAGCATGAGACG-3
LMCB-151R 5-CTAATTGGCTTGTTTGGGCTC-3
S1-T4 LMCB-74F 5-TCTGGGCAGCATGAGACG-3
LMCB-152R 5-TTACTCCTCCAAGGAGTAG-3
NCADt, with stop codon LMCB-109F 5-CTCGCCACCATGTGCCGGATAGCG-3
LMCB-150R 5-CTAACGCTCCTTATCACGGCGCTT-3
NCADt, with HpaI site LMCB-109F 5- CTCGCCACCATGTGCCGGATAGCG-3
LMCB-106R 5-CTAGGTTAACACGCTCCTTATCACGGCGCTT-3
NCADt/S1VC2 LMCB-107F 5-GATCGTTAACTCCTTGGAGGAGCCCAAACAA-3
LMCB-108R 5-GATCTCTAGATCAGGCGTAGAACTCCTCCTG-3
NCADt/S1V with stop codon HpaI LMCB-109F 5-CTCGCCACCATGTGCCGGATAGCG-3
LMCB-104R 5-CTACTCCTGCTTGGTGGGTTTCTG-3
S1-K293A LRI-282F 5-GAGGAGCCCGCACAAGCCAATGGC-3
LRI-283R 5-GCCATTGGCTTGTGCGGGCTCCTC-3
S1-Q294A LRI-284F 5-GAGGAGCCCAAAGCAGCCAATGGCGG-3
LRI-285R 5-CCGCCATTGGCTGCTTTGGGCTCCTC-3
S1-N296S/G297V LMCB-141F 5-CCCAAACAAGCCAGTTCGGTGCCTACCAG-3
LMCB-142R 5-CTGGTAGGCACCGACACTGGCTTGTTTGGG-3
S1-G297V/G298V LMCB-139F 5-AAACAAGCCAATGTCGTTGCCTACCAGAAA-3
LMCB-140R 5-TTTCTGGTAGGCAACGACATTGGCTTGTTT-3
S1-A299F LRI-255F 5- CAAGCCAATGGCGGTTTCTACAGAAACCCACC-3
LRI-256R 5-GGTGGGTTTCTGGTAGAAACCGCCATTGGCTTG-3
S1-Y300A LMCB-93F 5-AATGGCGGTGCCGCCCAGAAACCCACC-3
LMCB-94R 5-GGTGGGTTTCTGGGCGGCACCGCCATT-3
S1-Q301A LRI-257F 5-GCCAATGGCGGTGCCTACGCGAAACCCACCAAGCAG-3
LRI-258R 5-CTGCTTGGTGGGTTTCGCGTAGGCACCGCCATTGGC-3
S1-K302G LRI-271F 5-GGTGCCTACCAGGGACCCACCAAGCAGGAG-3
LRI-272R 5-CTCCTGCTTGGTGGGTCCCTGGTAGGCACC-3
S1-K305G LRI-273F 5-CAGAAACCCACCGGGCAGGAGGAGTTATAC-3
LRI-274R 5-GTAGAACTCCTCCTGCCCGGTGGGTTTCTG-3
S1-Q306A LRI-286F 5-CAGAAACCCACCAAGGCGGAGGAGTTC-3
LRI-287R 5-GAACTCCTCCGCCTTGGTGGGTTTCTG-3
S1-E307A LRI-288F 5-CCCACCAAGCAGGCGGAGTTCTACGCC-3
LRI-289R 5-GGCGTAGAACTCCGCCTGCTTGGTGGG-3
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vision Openlab. Excel worksheets (Microsoft, Redmond, WA) were used to
calculate descriptive statistics and to determine significance using unpaired
two-tailed t tests. The data were prepared for graphical presentation with
Prism 4.0 software (Sorrento, CA). Confocal XY images were taken under the
63 objective lens (zoom 1 to zoom 3) of a Leica TCS-SP/SP-AOSB laser
confocal microscope using Leica confocal software version 2.5. Confocal
images of wound-scratch preparations were taken under the 20 objective at
zoom 1–3.
Flow Cytometry
Adherent cells (COS-7 or C2C12) were harvested in nonenzymatic cell disso-
ciation solution (Sigma). Cell viability was tested by trypan blue exclusion
and the cells were resuspended at 107 cells/0.5 ml PBS and incubated with
antibody to mouse syndecan-1, chick NCAD, or isotype-matched controls, on
ice for 30 min. Cells were washed three times in PBS at 4°C, resuspended in
FITC-conjugated secondary antibody, and incubated for 30 min on ice. The
cells were washed again in PBS and passed through a Becton Dickinson
FACScan (San Jose, CA) using FlowJo software (Tree Star, San Carlos, CA),
with fluorescent excitation with an Argon laser (excitation at 488 nm and
emission 530  30 nm). The forward and side scatters were gated to exclude
small cells, debris, and cell aggregates. Twenty thousand events were ac-
quired per sample. A marker was set 1–2% above the maximum fluorescence
of the negative, isotype control-stained cells, and syndecan-1-expressing cells
with fluorescence above this level were scored as positively stained. Endog-
enous syndecan-1 on C2C12 or COS-7 cells was detected by the same proce-
dure. For 3D-migration measurements with transfected C2C12 cells, live
C2C12 cells were cotransfected with EGFP and syndecan-1 expression plas-
mids, or EGFP-fascin, and, after 40 h, sorted for EGFP expression using FACS
Vantage and Cellquest software (Becton Dickinson), resuspended in DMEM,
and used for experiments. Typically, the population sorted as EGFP-positive
was 6% of the total. At least three independent experiments were carried out
for each experimental condition.
Wound Healing Migration
C2C12 cells were plated at 2  105 cells per p60 tissue culture dishes for 40 h
until confluent. The cultures were wounded with a pipette tip, washed, and
reincubated with complete medium. Duplicate dishes were harvested at time
0 and at intervals up to 24 h and fixed in 2% paraformaldehyde. Cells were
stained for syndecan-1, actin, tubulin, or fascin as described above. The
experiment was repeated five times.
Three-dimensional Cell Migration
Polycarbonate filters (NeuroProbe, Cabin John, MD, 8-m-pore size) were
coated with different concentrations (in the range 5 nM–250 nM) of extracel-
lular matrix proteins (laminin, collagen IV, TSP-1, FN) or BSA as a negative
control overnight at 4°C and placed in a 96-well chemotaxis chamber (Neuro
Probe) containing 85 l DMEM in the lower chambers. The upper wells were
preincubated with 200 l DMEM. C2C12 cells were preincubated with inhib-
itory reagents as necessary, harvested, and resuspended at 7.5  103 cell/ml
in DMEM. One thousand five hundred cells in 200 l were added to the top
chamber and incubated at 37°C in a humidified, 5% CO2 atmosphere for 4 h.
Cells remaining on the top side of the filter were removed with a cotton tip
and cells that had migrated to the bottom were fixed with methanol and
stained with crystal violet (0.2% in 35% ethanol). Migrated cells were counted
under phase-contrast illumination using a 20 objective. Each condition was
tested in triplicate in each experiment. Data were pooled from three or more
independent experiments and analyzed statistically by unpaired t test.
RESULTS
The Role of the Cytoplasmic Domain of Syndecan-1 in
Transducing Fascin-and-Actin bundling and Cell
Spreading Depends on the V Region
The VC2 regions of syndecan-1 are necessary for transduc-
tion of cell spreading and bundling of F-actin by fascin,
when the extracellular domain is ligated and clustered either
by syndecan-1 antibody or by trimeric TSP-1 (Adams et al.,
2001). To determine whether clustering of VC2 alone is
sufficient to trigger cytoskeletal organization, we expressed
heterologously a chimeric protein consisting of the extracel-
lular, transmembrane, and membrane-proximal region of
chicken N-cadherin (N-CAD) fused to the VC2 region of
mouse syndecan-1 (designated NCADt/syn1VC2). N-CAD
truncated at the same membrane proximal region served as
a negative control (designated NCADt; Figure 1A). The two
proteins were expressed equivalently in COS-7 cells (Figure
1B) and were expressed similarly on the cell surface (Table
2A). Next, COS-7 cells were cotransfected with the NCAD
constructs plus EGFP-fascin and the effect of antibody-me-
diated clustering of NCAD was quantified according to cell
spreading and the assembly of actin-and-fascin bundles. The
monoclonal antibodies FA-5 and NCD-2 are specific to
chicken N-CAD and bind epitopes close to the N-terminus,
within the region responsible for homophilic cadherin bind-
ing (Hatta et al., 1986; Volk et al., 1990; reviewed by Gooding
et al., 2004). Expression of NCADt supported cell attachment
to each of these antibodies but did not result in cell spread-
ing or actin cytoskeletal organization. Cells expressing
NCADt/syn1VC2 attached in somewhat greater numbers
(mean of 120% relative to the attachment of NCADt-cells,
probably because some of the unspread NCADt-expressing
cells tend to detach during washing). The individual
NCADt/S1VC2-expressing cells spread strongly and assem-
bled fascin-and-actin bundles (Figure 1, C and D, shown for
FA-5 antibody only). These phenotypic effects did not de-
pend on expression of EGFP-fascin (unpublished data).
These results demonstrate that outside-in clustering of the
VC2 region of syndecan-1 at the plasma membrane is suffi-
Figure 1. Clustering of the VC2 region of syndecan-1 cytoplasmic
domain is sufficient for cell spreading and fascin-and-actin bun-
dling. (A) Schematic diagram of the chimeric constructs prepared.
(B) Equivalent expression of the two proteins in COS-7 cells, as
determined by immunoblot with antibody specific for chicken
NCAD. Molecular mass markers are indicated in kDa. (C) Morphol-
ogy and F-actin organization of COS-7 cells expressing either
NCADt or NCADt/S1VC2 after plating for 1 h on surfaces coated
with 50 g/ml antibody to chick NCAD extracellular domain and
staining with phalloidin. Bar, 10 m. (D) Quantification of the assay
from three independent experiments. Each column represents the
mean; bars, SEM. Over 1000 cells were scored in total for each
construct.
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cient to activate fascin-and-actin bundling and cell spread-
ing.
As a first approach to distinguish requirements for the V
or C2 regions in these processes, we prepared a set of four
C-terminal truncation mutants of mouse syndecan-1 that
deleted either the C2 region alone or C2 plus portions of the
V region (Figure 2A). COS-7 cells express endogenous syn-
decan-1 at a low level compared with myeloma cells, which
are known for strong expression of syndecan-1 (reviewed by
Sanderson and Borset, 2002; Table 2B). All the mouse syn-
decan-1 deletion proteins were expressed equivalently to
wild-type mouse syndecan-1 on the surface of COS-7 cells
(Table 2C). We previously demonstrated that expression of
wild-type mouse syndecan-1 in COS-7 cells enables cell
attachment and lamellipodial spreading on surfaces coated
with antibody to the extracellular domain of mouse synde-
can-1, in comparison to vector-control cells, which attach
only at same level as on BSA-coated surfaces and do not
spread (Adams et al., 2001). Cells expressing the truncations
T3 and T4 were significantly decreased in cell spreading
relative to wild-type syndecan-1. T2-expressing cells main-
tained a partial capacity to assemble fascin-and-actin bun-
dles, and bundling was significantly decreased in the T3-
and T4-expressing cells (Figure 2B). These findings indicated
that the C2 motif is not essential for these cytoskeletal re-
sponses and implicated the portion of the V region up to the
T3 deletion site in mediating the cell behaviors. To confirm
that the V region alone is sufficient, we compared the ability
of an NCAD chimera containing only the V region of syn-
decan-1, NCADt/syn1V, to support cell spreading and ac-
tin-bundling. Strikingly, NCADt/syn1V supported cell
spreading and actin bundling on NCAD antibody surfaces
to the same level as NCADt/syn1VC2 (Figure 2B). The
cell-attachment activity of the two proteins was equivalent
(unpublished data). These results identify a critical require-
ment for the V region in the mechanism of transduction of
spreading and cytoskeletal organization by syndecan-1.
Identification of Critical Determinants for Cell Spreading
and Fascin-and-Actin Bundling within the V Region of
Syndecan-1
To identify the molecular basis for this activity of the V
region, we prepared a series of point mutations in the con-
text of full-length mouse syndecan-1. The choice of mutation
sites was informed by our results with the deletion mutants
(Figure 2B), multiple sequence alignment of the cytoplasmic
domains of vertebrate syndecans (Figure 3A), and consider-
ation of the NMR structure of syndecan-4 cytoplasmic do-
main peptides (Shin et al., 2001). The multiple sequence
alignment documents three key points about the cytoplas-
mic domains of syndecans, two of which have been widely
discussed: 1) the complete conservation of the C1 and C2
Table 2. Surface expression of syndecan-1 proteins in COS7 or IM-9 myeloma cells determined by live-cell staining and flow cytometry
Sample
% of cells expressing syndecan-1
or heterologous protein
Fluorescent
intensity
A Isotype control ND 11.6 1.3
NCADt 86.1 1.9 263.5  19.5
NCADt.S1VC2 84.5 1.6 211.0  25.0
NCADt.S1V 84.0 2.0 211.0  26.5
B
IM9 cells Isotype control ND 22.4 0.9
ID4 (anti-syndecan-1 mab) 94.4 0.7 174.0  7.9
COS-7 cells ID4 (anti-syndecan-1 mab) 87.0 2.0 46.0  1.0
C Isotype control ND 29.7 2.3
mS1-WT 74.0 6.0 306.6  28.4
mS1-T1 68.5 13.5 353.9  9.2
mS1-T2 73.5 9.5 314.0  45.0
mS1-T3 55.5 5.5 361.5  28.5
mS1-T4 70.5 9.5 370.4  13.4
D Isotype control ND 35.5 2.4
mSI-WT 47.0 1.4 462.0  74.6
mS1-K293A 61.5 1.9 620.2  119.0
mS1-Q294A 56.1 4.1 549.0  119.0
mS1-N296S/G297V 51.1 9.2 464.8 18.8
mS1-G297V/G298V 49.1 0.3 586.0  32.0
mS1-A299F 56.9 0.9 509.0 117.7
mS1-Y300A 53.0 5.8 345.0  133
mS1-Y300E 50.8 1.2 561.0  20.0
mS1-Q301A 55.0 12.0 440.0  136.0
mS1-K302A 55.9 3.9 471.0  74.0
mS1-K305A 56.1 1.6 527.0  88.0
mS1-Q306A 58.7 4.5 611.8  53.4
mS1-E307A 53.713.7 486.7  28.6
mS1-M4* 47.22.8 474.0  63.2
mS1-M5ˆ 59.7 9.2 750.9  65.0
mS1-M5Y300E 53.5  3.8 609.0  0.1
mS1-M5K302A 56.6  0.5 540.0  106.8
mS1-M5Q306A 51.6  1.0 497.0  106.0
Values are mean  SEM from 3–5 experiments. ND, not determined.
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regions across the whole syndecan family; and 2) the closer
sequence similarity between the V regions of syndecan sub-
family members (i.e., between syndecan-1 and -3, vs. syn-
decan-2 and -4; reviewed by Bernfield et al., 1999; Couch-
man, 2003). An additional third feature that we noted from
the alignment was that even within the V regions, certain
residues are highly conserved across the family (asterisked
in the figure), whereas the central regions of syndecans-1, -2,
and -3 contain distinct sequences and can be considered
hypervariable. Syndecan-4 has the shortest cytoplasmic do-
main, and although its V region aligns overall with that of
syndecan-2, a distinct central motif is not apparent (Figure
3A).
We prepared single point mutations across the region aa
293–307 of mouse syndecan-1 and included double point
mutations within the hypervariable region. We included
K293 and Q294 in the screen because K189 and K190 of
syndecan-4 (which align with K293 and Q294 of syndecan-1)
are involved in ionic interactions that stabilize syndecan-4
cytoplasmic domain as an intertwined dimer (Shin et al.,
2001). Syndecan-1 cytoplasmic domain peptides do not
dimerize (Oh et al., 1997); however, we wanted to consider
the significance of possible ionic interactions of K293 and
Q294. Most target residues were substituted with alanine
residues, but where the natural residue was a small amino
acid (e.g., A299), an amino acid from the same charge group
with a large side group was substituted. Y300 has been
implicated as a possible site of tyrosine phosphorylation that
affects the colocalization of syndecan-1 with F-actin (Carey et
al., 1996); therefore both Y300A and Y300E point mutations
were prepared. All the V region point mutants were ex-
pressed on the cell-surface of COS-7 cells at levels equivalent
to or slightly higher than wild-type syndecan-1 (Table 2D).
We quantified the activity of the V region mutants in the
syndecan-1 antibody adhesion assay in comparison to wild-
type syndecan-1 by scoring three morphometric parameters:
cell area, the number of fascin-and-actin bundles per cell,
and the length of the fascin-and-actin bundles assembled by
each cell (as illustrated in Figure 3B). These analyses uncov-
ered that mutations at multiple sites partially inhibited the
F-actin-organizational activities of syndecan-1. For cells ex-
pressing wild-type syndecan-1, the mean cell area was 896
79 m2, the mean number of actin-and–fascin bundles per
cell was 38  2, and the mean length of the bundles was
5.26  0.21 m (n  90 cells scored from 6 independent
Figure 2. The V region of syndecan-1 cytoplasmic domain is nec-
essary for cell spreading and fascin-and-actin bundling. (A) Sche-
matic diagram of the syndecan-1 deletion constructs prepared. (B)
Quantification of transfected COS-7 cell spreading and fascin-and-
actin bundling activities in syndecan-1 or NCAD adhesion assays.
Each column shows the mean  SEM for data from five indepen-
dent experiments. One hundred cells were scored in each experi-
ment.
Figure 3. Identification of critical residues within the V region of syndecan-1. (A) ClustalW multiple sequence alignment of the cytoplasmic
domains of vertebrate syndecans. Black shading shows identical amino acids; gray indicates conservative substitutions and no shading
indicates unrelated amino acids. Cg, Cricetulus griseus; Dr, Danio rerio; Gg, Gallus gallus; Hs, Homo sapiens; Mm, Mus muscularis; Rn, Rattus
norvegicus; Xl, Xenopus laevis. Asterisk indicate conserved positions within the V region. (B) Morphometric scoring parameters used in the
experiments with syndecan-1 point mutants transfectants. COS-7 cells expressing EGFP-fascin and mouse syndecan-1, adherent on antibody
to mouse syndecan-1, were scored for cell area (white outline) and the number and length of fascin-containing bundles (white bar) using
Openlab software. Bar, 10 m.
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experiments). The most significant effects, corresponding to
about a 40% decrease in cell area, were caused by the mu-
tations Q294A, G297V/G298V, Y300E, or Q306A (Figure
4A). The Y300A mutation had activity similar to that of
wild-type syndecan-1 (Figure 4A). Certain other mutations:
K293A, Q301A, K305A, and E307A, decreased cell area by
25–30%. The number of fascin-and-actin bundles per cell
was most strongly decreased by the Y300E mutation (Figure
4B, significantly different from wild-type at p  0.0003), and
expression of the mutations Q294A, G297V/G298V, K302A,
K305A, and Q306A all resulted in minor decreases in the
number of bundles per cell. The residual actin and fascin
bundles formed by cells expressing mutant syndecans were
similar in length to those formed by cells expressing wild-
type syndecan-1 (Figure 4C). Only the G297V/G298V,
Q301A, or K305A mutants consistently resulted in the as-
sembly of actin-and-fascin bundles that were modestly but
significantly shorter (Figure 4C).
We next investigated the combined effects of the point
mutations that resulted in the most impaired activity: that is,
Q294, G297V/G298V, Y300E, and K305. Expression of the
mutant combination S1:Q294A/G297V/G298V/K305A
(designated S1MUT4) resulted in significantly decreased cell
area, number of fascin-and-actin bundles, and length of the
bundles relative to wild-type syndecan-1; however, the per-
centage decreases in cell area or number of bundles were no
greater than the effects of the functionally compromised
single point mutations (Figure 4, A–C). We therefore in-
cluded an additional mutation in the S1MUT4 construct.
S1MUT5 (S1:Q294A/G297V/G298V/Q301A/K305A) was
clearly less active with regard to cell spreading and the
number of fascin-and-actin bundles per cell (Figure 4, A–C).
Out of several additional mutants prepared within the
MUT5 construct, S1MUT5Y300E was the least active: cell
area was reduced by 50% (significant at p  0.0001) and the
number of fascin and actin bundles per cell by 60% (signif-
icant at p  0.00003) relative to cells expressing wild-type
syndecan-1 (Figure 4, A–C). The reduced activity of
S1MUT5Y300E was specific to the introduction of the
Y300E point mutation because S1MUT5Q306A or
S1MUT5K302A were not significantly different in activity
to MUT5 (Figure 4, A–C). Interestingly, none of the combi-
nation mutants differed significantly from single point mu-
tants with regard to the length of the residual fascin-and-
actin bundles (Figure 4C). These results identify major roles
of syndecan-1 V region in transducing cell spreading and the
initiation of fascin-and-actin bundling.
Inhibition of Cell Spreading and Fascin-and-Actin
Bundling by a V-region-containing Peptide
The importance of the V region in the mechanism of trans-
ducing spreading and actin bundle organization was sub-
stantiated by a third independent methodology, that of ex-
amining the effects of a membrane-permeable synthetic
peptide consisting of the 12-residue polybasic, membrane-
penetrating region of the HIV TAT protein and the synde-
can-1 V region, TAT-S1V. TAT peptides are widely used as
soluble, membrane-permeable competitors of intracellular
protein-protein interactions (Becker-Hapak et al., 2001).
TAT-S1V peptide entered COS-7 cells with high efficiency
within a 1-h period and without any effect on cell viability at
concentrations below 2 M (unpublished data). Cells treated
with TAT-S1V showed a concentration-dependent decrease
in syndecan-1-activated spreading, with at maximum a 46%
reduction in cell area (Figure 5A) and a 25% reduction in the
numbers of actin-and-fascin bundles (Figure 5B). The length
of the remaining bundles was decreased by 30%, from a
mean of 5.0  0.4 to 4  0.7 m (Figure 5C). Cells treated
with TAT peptide containing a scrambled V region se-
quence, TAT-S1Vscr, or TAT peptide alone, were indistin-
guishable from untreated control cells for all three parame-
ters (Figure 5, A–C). A TAT-peptide containing the
syndecan-1 V sequence mutated at five of the positions that
have the greatest combined effect in inhibiting the activities
of full-length syndecan-1, TAT-S1VMUT5, was also inactive
(Figure 5, A–C).
V region-dependent Transduction of Cytoskeletal
Responses Depends on a Detergent-insoluble Form of
Cell-surface Syndecan-1
Having identified a novel specific requirement for the V
region in the mechanism of cytoskeletal organization by
Figure 4. Identification of critical residues within the VC2 region
of syndecan-1. Quantification of the effects of syndecan-1 point
mutants on COS-7 cell spreading and fascin-and-actin bundling in
the syndecan-1 adhesion assay. (A) cell area; (B) number of fascin-
and-actin bundles per cell; (C) length of fascin-and-actin bundles.
Each column shows the mean  SEM for data pooled from at least
three independent experiments. * Significantly different from wild
type at p  0.002.
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Figure 5. Effect of a membrane-permeable TAT-S1V peptide on cell spreading and syndecan-1 extractability. Transfected COS-7 cells were
preincubated with TAT peptides, as indicated, for 1 h before harvesting. Syndecan-1 adhesion assays were carried out for 1 h in the continued
presence of peptide. (A–C) Quantification of the effects of TAT peptides on cell spreading and fascin-and-actin bundling. Each graph data
point or column indicates the mean  SEM for data from five independent experiments. In B and C, each peptide was used at 1200 nM.
*Significantly different from untreated control at p  0.001. (D) Effects of TAT peptides on detergent extractability of syndecan-1. Cells were
prepared either fixed or fixed and permeabilized. Mouse syndecan-1 was detected on the adherent cells with biotin-conjugated primary
antibody and FITC-conjugated streptavidin, and cells were analyzed by confocal XY and XZ images. Arrow indicates example of alignment
of syndecan-1 at sites of F-actin bundles. Each peptide was used at 1200 nM. Under control conditions, ligated syndecan-1 was specifically
resistant to extraction (top row), and this property was specifically inhibited by TAT-S1V peptide (third row). Results shown are
representative of five independent experiments. Bar, 10 m.
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syndecan-1, we took further steps to analyze its mechanism
of action. Because the clustering of syndecan-1 transmem-
brane and cytoplasmic domains has been reported to result
in incorporation into a detergent-insoluble fraction (Fuki et
al., 2000), we examined how different states of cytoskeletal
organization correlate with detergent-solubility of synde-
can-1. In cells expressing wild-type mouse syndecan-1, ad-
herent on syndecan-1 antibody, syndecan-1 had a diffuse
localization across the lamellipodia and cell bodies of non-
permeabilized cells, with some enrichment at sites of F-actin
bundles (Figure 5D, top row, and unpublished data). Cell-
surface syndecan-1 was retained after detergent-extraction
of the cells, as demonstrated in XZ sections (Figure 5D, top
row, side panel). For comparison, we examined syndecan-1
extractability in cells adherent on fibronectin, where focal
adhesions dominate, the actin-bundling activity of fascin is
down-regulated and overexpression of syndecan-1 does not
alter cell morphology or actin organization (Adams et al.,
1999, 2001). Under these conditions, syndecan-1 also had a
diffuse distribution on the surface of fixed cells but was
completely detergent-extractable upon permeabilization
(Figure 5D, second row).
To examine how extractability relates to the activity of the
V region, the extractability of syndecan-1 was examined in
cells pretreated with the TAT syndecan peptides. Pretreat-
ment of cells with TAT-S1V peptide resulted in near-total
detergent-extractability of syndecan-1 (Figure 5D, third
row). This effect was specific to TAT-S1V peptide, because
pretreatment of cells with TAT, TAT-S1Vscr, or TAT-
S1VMUT5 peptides did not result in syndecan-1 extraction
upon detergent treatment (Figure 5D, bottom row, shown
for TAT-S1Vscr only). From these data, we conclude that the
TAT-S1V peptide acts as a specific soluble cytoplasmic in-
hibitor of interactions of syndecan-1 V region that are nor-
mally activated by ligation of the extracellular domain of the
core protein and which result in resistance of cell-surface
syndecan-1 to detergent extraction in correlation with its
activity in promoting cell-spreading and actin-bundling by
fascin.
ECM Ligands Regulate the Extractability of Endogenous
Cell-surface Syndecan-1 by a V Region-dependent Process
To extend our findings to the physiological ligation of syn-
decan-1 by ECM ligands, we examined the detergent ex-
tractability of the endogenous syndecan-1 of mouse C2C12
skeletal myoblasts plated on individual ECM components.
As expected from our previous experiments, direct antibody
ligation of syndecan-1 on C2C12 cells resulted in a lamelli-
podial phenotype with multiple cell protrusions (Adams et
al., 2001; Figure 6A). In fixed cells, syndecan-1 was distrib-
uted across the cell surface, with concentration on cell pro-
trusions and in alignment with actin filaments (Figure 6A
and unpublished data). This cell-surface syndecan-1 was
highly resistant to detergent extraction (Figure 6A, XY and
XZ). C2C12 cells also tended to have more intracellular
syndecan-1 than COS-7 cells (compare Figure 6A with 5D).
Cells adherent on EHS laminin, another known ligand of
syndecan-1 (Suzuki et al., 2003; Yamashita et al., 2004), which
also supports fascin protrusions (Adams, 1997), were more
smooth-edged. Cell-surface syndecan-1 was again resistant
to detergent-extraction (Figure 6A). C2C12 cells on TSP-1
had elongated or protrusive, ruffling morphologies. Synde-
can-1 was distributed over the cell surface, with some con-
centration on ruffling membranes and was also highly resis-
tant to detergent extraction (Figure 6A).
To establish whether the V region of syndecan-1 partici-
pates in the resistance of the cell-surface, ECM-ligated syn-
decan-1 to extraction, we tested syndecan-1 extractability in
laminin-adherent C2C12 cells after treatment with the TAT-
syndecan peptides. Pretreatment with TAT-S1Vscr did not
alter the ability of C2C12 to attach and spread on laminin,
nor did it alter the resistance of cell-surface syndecan-1 to
extraction (Figure 6B). In contrast, pretreatment with TAT-
S1V resulted in cell-rounding, a patchy distribution of cell-
surface syndecan-1 and increased extractability of synde-
can-1 (Figure 6B, XY and XZ images). These data implicate
the V region of syndecan-1 in the mechanism of cytoskeletal
responses activated by physiological ECM ligands of synde-
can-1.
Functional Role of the V region of Syndecan-1 in Cell
Migration
In view of the roles we had identified for syndecan-1 V
region in cytoskeletal organization and adhesion to specific
ECM ligands, it was of interest to establish whether the
reported function of syndecan-1 in cell migration also de-
pends on the V region. First, we examined the distribution of
syndecan-1 in migrating cells. In dense cultures of C2C12
cells where there is little directional cell migration, synde-
can-1 was nonpolarized and diffuse (Figure 7A, time 0).
When directional cell migration was stimulated by wound-
scratch across the culture, the front row of cells initially
become flattened, with characteristic lamellipodia and fas-
cin- and actin-containing ruffles at their leading edges and
elongated microtubules behind the zone of ruffling (Figure
7A, 2- and 4-h time points). Syndecan-1 was highly concen-
trated at lamellipodial edges where it colocalized with F-
actin at the 2- and 4-h time points (Figure 7A, F-actin/
syndecan-1 merged images and unpublished data). By 24 h,
cells were less flattened and syndecan-1 was distributed
over cell bodies as well as at leading edges (Figure 7A).
These observations suggested that syndecan-1 might have a
specific role in the initiation of polarized cell migration.
To test this idea, we examined the role of syndecan-1 in
3-D transfilter migration. C2C12 cells and other skeletal
myoblasts undergo 2-D haptotactic migration on a number
of ECM components, including thrombospondin-1 (TSP-1),
fibronectin, and laminin (Adams and Schwartz, 2000 and
unpublished data). In various cell types, syndecan-1 is a
known ligand of these glycoproteins and also of collagens I
and IV (Sanderson et al., 1992; San Antonio et al., 1994;
Lebakken and Rapraeger, 1996; Suzuki et al., 2003; Ya-
mashita et al., 2004). C2C12 cells underwent 3-D transfilter
migration in response to fibronectin, EHS laminin, TSP-1, or
collagen IV. Within a 4-h period and with testing of a broad
range of concentrations of each ECM component, EHS lami-
nin produced the highest number of migrating cells, and
collagen IV and TSP-1 had the lowest activities at each
concentration tested (unpublished data). We therefore fo-
cused on migration in response to laminin as the most
amenable to experimentation.
In a further set of control experiments, we examined the
mode of 3-D cell migration of C2C12 cells. Recent reports
have distinguished several forms of 3-D cell migration: fi-
broblasts undergo ECM-adhesive crawling in combination
with proteolytic cleavage of ECM fibrils, whereas lympho-
cytes and certain tumor cells move by a nonproteolytic
gliding, amoeboid motion (Sahai and Marshall, 2003; Wolf et
al., 2003). Both modes of migration are susceptible to inhi-
bition by disruption of the actin or microtubule cytoskel-
etons, but can be distinguished by their sensitivity to Rho-
kinase inhibitor: amoeboid motility is not inhibited by
Rho-kinase inhibitor, whereas fibroblast-like crawling is
(Wolf et al., 2003; Sahai and Marshall, 2003). C2C12 cell
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migration on laminin was completely blocked when cells
were treated with cytochalasin D. Perturbation of microtu-
bules, either by paclitaxel or vinblastine, also substantially
prevented migration. The Rho-kinase inhibitor Y27632 in-
hibited migration to the same extent as the actin and micro-
tubule inhibitors (Figure 7B). These results identified that
C2C12 cells undergo a fibroblast-like form of 3-D cell migra-
tion.
To establish whether syndecan-1 was involved in laminin-
induced C2C12 migration, we compared the migration of
cells pretreated with either TAT-S1V or control TAT pep-
tides. Although cells treated with TAT-S1Vscr or TAT-
S1VMUT5 migrated to the same extent as control cells, the
number of cells migrating after TAT-S1V peptide treatment
was inhibited by 50% (Figure 7C). Pretreatment of the cells
with antibody to syndecan-1 extracellular domain enhanced
cell migration in a concentration-dependent manner (Figure
7C). These findings indicated that the activity state of syn-
decan-1 regulates 3-D laminin-dependent cell migration and
that the V region has a role in this process.
To substantiate the mechanistic role of the V region,
C2C12 cells were cotransfected with wild-type syndecan-1
or the point mutant forms that we had identified to be most
impaired in cytoskeletal-organization activities: Y300E,
MUT5, and MUT5Y300E, and with EGFP to mark the
transfected cells. All the syndecan-1 proteins were expressed
equivalently on the surface of C2C12 cells (unpublished
data). EGFP-positive cells were selected by gated flow cyto-
metric sorting and tested for transfilter migration on lami-
nin. The cells expressing EGFP only or EGFP-fascin had the
same migration characteristics as control, untransfected
C2C12 cells; however, cells overexpressing wild-type synde-
can-1 were markedly reduced in their ability to migrate
(Figure 7D, difference to controls significant at p  0.005).
The extent of inhibition was as substantial as that obtained
by pharmacological disruption of the cytoskeleton (compare
Figure 7, B and D). This activity was not due to binding of
the GAG chains to laminin, because syndecan-1 mutated at
the three heparin sulfate addition sites (TDM mutant; Lang-
ford et al., 1998) that retains matrix-attachment activity (Ad-
ams et al., 2001) had equivalent activity to wild-type synde-
can-1 (Figure 7D).
In contrast, MUT5Y300E-expressing cells were signifi-
cantly more migratory than the cells expressing wild-type
syndecan-1, indicating that the wild-type V region contrib-
utes to the slowing of cell migration by syndecan-1 (Figure
Figure 6. Adhesion to ECM ligands ren-
ders endogenous syndecan-1 nonextract-
able. (A) C2C12 cells were plated on sur-
faces coated with 50 g/ml antibody to
mouse syndecan-1; 50 nM EHS laminin, or
50 nM TSP-1 for 3 h. Syndecan-1 extractabil-
ity was assessed by staining cells with bi-
otin-conjugated primary antibody and
FITC-conjugated streptavidin after fixation
or after fixation and permeabilization. Cells
were viewed as confocal XY or XZ sections.
Bar, 10 m. (B) Treatment with TAT-S1V
peptide renders endogenous syndecan-1 de-
tergent-extractable in laminin-adherent
C2C12 cells. Cells were pretreated with 1200
nM TAT-S1V or control TAT-S1Vscr pep-
tides for 2 h before adhesion on 50 nM lami-
nin in the continued presence of peptides as
described above. Bar, 10 m.
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Figure 7. Syndecan-1 localizes to leading edge of migrating cells and has a functional role in 3-D cell migration. (A) C2C12 cells were grown
to confluency and wounded with a micropipette tip. At different times after wounding, dishes were fixed, permeabilized, and stained for
syndecan-1. At 4 h, syndecan-1 was most concentrated at the front of migrating cells, along with fascin and F-actin. -tubulin was present
behind the ruffling edges. Representative merged images are shown for actin and -tubulin, and actin and syndecan-1. Bars, 10 m. (B–D)
Quantification of transfilter cell migration assays. Pore filters, 8-m, were coated with 50 nM EHS laminin or 1 mg/ml BSA. TAT-S1V and
TAT-S1Vscr peptides were added at 1200 nM. With the exception of syndecan-1 antibody, which was added only during the assay, C2C12
cells were preincubated with reagents at the concentrations indicated for 1 h and then harvested, and the experiments were carried out in
the continued presence of each reagent. Each condition was carried out in triplicate in each experiment, and transfilter migration was scored
after 4 h. DMSO, dimethyl sulfoxide; PcT, paclitaxel; VBS, vinblastine sulfate; CytoD, cytochalasin D. In D, C2C12 cells coexpressing
wild-type or mutant syndecan-1 and EGFP or EGFP-fascin were sorted by flow cytometry, and 1500 EGFP-positive cells were added to each
well coated with 50 nM EHS laminin. After 4 h at 37°C, cells that had migrated to the far side of the filter were fixed, stained, and counted
under phase-contrast illumination. Each condition was carried out in triplicate in each experiment. Columns represent mean  SEM for data
from at least three independent experiments.
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7D, p  0.008). The Y300E mutation alone reduced cell
migration to the same level as wild-type syndecan-1 (Figure
7D). Under each condition, residual cell migration was al-
most completely inhibited by Y27632, indicating that the
mode of cell migration was not altered by the overexpres-
sion of syndecan-1 or syndecan-1 V region mutants (unpub-
lished data). These data demonstrate a role for the V region
in the modulation of cell migration by syndecan-1.
DISCUSSION
Within the family of mammalian syndecans, syndecan-1 has
been linked to the modulation of cell proliferation, migra-
tion, and the regulation of the actin cytoskeleton. Thus,
syndecan-1 has completely distinct activities from synde-
can-4, which cooperates in the assembly of contractile focal
adhesions (reviewed by Couchman, 2003), or syndecan-2,
which is involved in the assembly of dendritic spines or the
ECM (Ethell et al., 2001; reviewed by Tkachenko et al., 2005).
Although mechanisms of signaling by syndecan-2 and -4 are
known to depend on their V regions, there is no knowledge
of the specific roles of syndecan-1 V region. In this study, we
establish for the first time that critical determinants for trans-
ducing cytoskeletal organization in response to antibody
ligation or physiological ECM ligands lie within aa 294–307
of the unique V region of syndecan-1. By four criteria (de-
letion mutants, point mutants, NCAD chimeras, and use of
TAT-V peptide), the C2 region is not essential for this activ-
ity. We demonstrate that upon ligation and clustering either
by antibody or ECM ligands, cell-surface wild-type synde-
can-1 enters a detergent-resistant state and that this state
depends on the V region. We have also identified a role of
the V region in 3-D cell migration.
Our analysis of syndecan-1 deletion mutants focused at-
tention on aa 297–307 as critical for cell spreading and actin
bundling (Figure 2). The analysis of point mutations within
the V region then revealed a complex functionality of the
region. Of the 12 single or double point mutations prepared,
7 resulted in partial impairment of cell spreading and 5 of
these also significantly decreased the number of fascin-and-
actin bundles (Figure 4). More severe phenotypes were ob-
tained when the most inhibitory mutations were combined
together, resulting in similar levels of inhibition of cell
spreading and fascin-and-actin bundle assembly. The func-
tion-perturbing mutations corresponded to a subset of the
amino acids that are conserved across all syndecan V regions
and to the unique GG motif within the syndecan-1 V region
hypervariable domain (Figure 4A). Further experiments will
be needed to establish if these residues are important for the
structure of syndecan-1 cytoplasmic domain or for func-
tional protein-protein interactions or both. K189 and K194 of
syndecan-4, which align with K293 and K302 of syndecan-1,
are important for the ionic interactions by which syndecan-4
cytoplasmic domains form obligate dimers (Shin et al., 2001).
Syndecan-1 and -2 cytoplasmic domains do not dimerize in
solution (Oh et al., 1997); however, it is likely that all syn-
decan cytoplasmic domains oligomerize in vivo by lateral
interactions as a result of activation and self-association of
their extracellular and transmembrane domains (reviewed
by Couchman, 2003). Ionic interactions of the conserved
positively charged residues could also be important in this
process.
The mutation of Y300 to glutamic acid impaired actin
organization activity. Constitutive tyrosine phosphorylation
of syndecan-1 occurs in lymphoma cell lines, but the resi-
dues phosphorylated and functional significance are un-
known (Ott and Rapraeger, 1998). Although the Y300E mu-
tation clearly impaired function in our experimental system,
the Y300A did not (Figure 4). It is also the case that the
surrounding amino acids do not conform to a consensus
tyrosine kinase phosphorylation motif (established by
search of PROSITE). Thus, the effect of the Y300E mutation
is more likely due to the change of charge and side group
than to phosphomimetic activity.
Interestingly, the activity of syndecan-1 in lamellipodial
spreading and actin bundling correlated with incorporation
of syndecan-1 into a detergent-insoluble fraction. This pro-
cess was specific, because upon cell adhesion to fibronectin
that involves a different state of cytoskeletal organization,
overexpression of syndecan-1 does not result in alterations
to cytoskeletal organization and syndecan-1 is detergent-
extractable (Figure 5). Detergent-insolubility of membrane
proteins has been related to their incorporation into choles-
terol-rich membrane microdomains and to signaling across
the plasma membrane (Simon and Ikonen, 1997). Indeed, we
have found that cholesterol-depletion by -methyl cyclodex-
trin renders cell-surface syndecan-1 constitutively deter-
gent-extractable and results in build-up of intracellular syn-
decan-1 (unpublished observations). Thus, signaling by
syndecan-1 to the cytoskeleton appears to depend on its
incorporation into lipid rafts.
An important outcome of our studies was the distinction
revealed between effects of syndecan-1 on cell-spreading,
the number of fascin-and-actin bundles per cell and the
length of any residual bundles. The independent approaches
taken to perturb wild-type syndecan-1 function: point mu-
tation of syndecan-1 or use of TAT-S1V peptide consistently
had significant effects on cell spreading and the numbers of
fascin-and-actin bundles, yet the length of any remaining
bundles was consistently less significantly altered (Figures 4
and 5). Both cell spreading and the assembly of fascin-and-
actin bundles depend initially on actin nucleation and poly-
merization. In the spread lamellipodium, actin filaments are
assembled as a branched network, in general by the action of
Arp2/3 complex (Pollard and Borisy, 2003). Correlated im-
munofluorescence and electron microscopic analysis has un-
covered that fascin and F-actin bundles in the lamellipodia
of melanoma cells are initiated from preexisting actin micro-
filaments within the lamellipodium that become clustered at
cell margins by an activity of vasodilator-stimulated phos-
phoprotein, (VASP), and then elongated into parallel bun-
dles by the cross-linking activity of fascin (Svitkina et al.,
2003). The quantitatively distinct effects of syndecan-1 per-
turbation on cell area and bundle number versus the length
of residual bundles in our study strongly imply that synde-
can-1 specifically regulates F-actin organization at the level
of cell spreading and bundle initiation, with bundle elonga-
tion under separate downstream regulation. Thus, any bun-
dles that do initiate under the inhibitory conditions continue
to elongate to the same length as in control cells. With regard
to the initiation process, we envision that activation of syn-
decan-1 may recruit and/or activate components necessary
for actin nucleation or filament assembly and that the re-
cruitment of fascin to prebundle sites can be controlled
separately from its F-actin cross-linking activity. Indeed, we
previously placed activation of the known regulators of
actin nucleation, Cdc42 and Rac, upstream of TSP-1-induced
cell spreading and fascin-and-actin bundle assembly (Ad-
ams and Schwartz, 2000). Understanding how actin is as-
sembled and bundles initiate as a result of syndecan-1 sig-
naling will require identification of binding partners of the
syndecan-1 V region.
Our data also demonstrate that the activity of syndecan-1
V region is necessary in the physiological responses of cells
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to ECM ligands and the regulation of cell migration. In vivo,
down-regulation of syndecan-1 on invasive carcinoma cells
and up-regulation on tumor-associated fibroblasts are both
associated with activation of tumor cell migration (Timar et
al., 2002). Either gene knockout or overexpression of synde-
can-1 result in reduced cell migration during wound-healing
(Stepp et al., 2001; Elenius et al., 2004). Thus, as established
for many proteins that function in cell migration (reviewed
by Webb et al., 2003), a certain balance of syndecan-1 expres-
sion appears to be necessary to support optimal cell migra-
tion. We found that the endogenous syndecan-1 of C2C12
cells becomes localized in leading edge ruffles after wound-
ing of a cell monolayer, suggestive of a role in directional
cell migration. In agreement with other reports, overexpres-
sion of syndecan-1 inhibited 3-D cell migration, probably
due to stabilization of cell protrusions leading to decreased
adhesion dynamics. We established the role of the V region
in this activity by two criteria: specific inhibition of migra-
tion involving endogenous syndecan-1 by TAT-V peptide
and the much reduced activity of the S1MUT5Y300E protein.
We note that the mutant did not completely restore migra-
tion to control levels, which suggests that other domains of
syndecan-1, for example, the transmembrane and extracel-
lular domain, might contribute to its inhibitory activity
(Langford et al., 2005). In summary, we have identified a
mechanism for syndecan-1 signaling to specific states of
cytoskeletal organization that is dependent on the molecular
nature of the V region and on incorporation of syndecan-1
into a detergent-insoluble form.
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